2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Primary Drivers Are Supporting the Continued Market Growth of theMethenamine Hippurate Tablets Market?

The methenamine hippurate tablets market is set to expand due to the growing geriatric population. This group includes individuals who are 60 years or older, who are at a higher risk of developing urinary tract infections because of factors such as decreased urine flow, an enlarged prostate, or kidney stones. Consequently, methenamine hippurate tablets are necessary to treat these conditions. The World Health Organization, a United Nations agency located in Switzerland responsible for global public health, reports that by 2030, one in six people worldwide will be aged 60 or above. In 2022, the global population had 1.4 billion people aged 60 and above. The global population of individuals aged 60 and over will double by 2050 (2.1 billion), and the population of those aged 80 or more is predicted to triple, reaching 426 million. Hence, the burgeoning geriatric population is a key growth driver for the methenamine hippurate tablets market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

#What Long-Term Growth Rate is Expected for theMethenamine Hippurate Tablets Market Between 2025 and 2034?

In recent times, the market size of methenamine hippurate tablets has seen significant growth. The market, which stood at $9.52 billion in 2024, is projected to increase to $10.21 billion in 2025, implying a compound annual growth rate (CAGR) of 7.2%. This growth during the historical period can be linked to traditional UTI treatments, worries about antibiotic resistance, clinical validation, physician prescribing habits, and patients’ preference for non-antibiotic solutions.

The size of the market for methenamine hippurate tablets is predicted to experience substantial growth in the coming years, increasing to a worth of $13.78 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. This upward trend during the forecast period is likely due to factors such as the increasing occurrence of UTI, heightened concerns over antibiotic resistance, progress in UTI management, a shift in healthcare towards preventive therapies, as well as ongoing clinical trials and research. The forecast period is also expected to witness significant trends like the escalation in UTI cases, growing antibiotic resistance, a preference for non-antibiotic treatments, emphasis on preventive healthcare, and intensive research and development.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9412

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theMethenamine Hippurate Tablets Market?

The primary trend impacting the methenamine hippurate tablets market is the introduction of innovative products. Firms in this market, including some of the largest players, are focusing their efforts on developing creative solutions to solidify their market standing. For example, EQL Pharma, a European pharmaceutical company that specializes in affordable generic medications and niche generics for hospitals and pharmacies, disclosed its plans in May 2023 to license Memprex (methenamine hippurate) to Laboratoires Majorelle for distribution in France. This step seeks to increase its accessibility and offer an alternative to antibiotics for UTI prevention. Laboratoires Majorelle, a key player in women’s health sector in France, will take charge of marketing and distributing Memprex, further offering an antibiotic-free option for UTI prophylaxis.

Who Are the Key Market Players Influencing the Growth of the Corn and Methenamine Hippurate Tablets Industry?

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

Which Key Market Segments Comprise the Methenamine Hippurate Tablets Market and Drive Its Revenue Growth?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp

Which Regions Are Emerging as Leaders in the Methenamine Hippurate Tablets Market?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Methenamine Hippurate Tablets Maret 2025, By The Business Research Company:

Medical Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-foods-global-market-report

Contraceptives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

Oral Contraceptive Pills Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: